NCT02993029 99Tc-MDP Treatment for Knee Osteoarthritis
| NCT ID | NCT02993029 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Xinhua Hospital, Shanghai Jiao Tong University School of Medicine |
| Condition | Treatment Outcome |
| Study Type | INTERVENTIONAL |
| Enrollment | 40 participants |
| Start Date | 2017-09-01 |
| Primary Completion | 2027-12-30 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.
This trial targets 40 participants in total. It began in 2017-09-01 with a primary completion date of 2027-12-30.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
Osteoarthritis (OA) of knee is the most common form of arthritis in the world1e, and it has received growing attention in the society because of the increase of old age population, disabled people, and medical expenses from this disease. 99Tc-MDP is effective for rheumatoid arthritis. Therefore, the investigators try to investigate the effects of 99Tc-MDP treatment in patients with osteoarthritis of knee as compared with celecoxib.
Eligibility Criteria
Inclusion Criteria: 1. Participants with painful osteoarthritis; 2. The standard uptake value (SUV) of OA related knee greater than 10 on 18F- sodium fluoride bone scan; 3. Participants voluntarily participate in the trial, and signed the informed consent. Exclusion Criteria: 1. Knee joint replacement; 2. Inflammatory arthritis or joint infection of knee; 3. Nervous joint disease; 4. Fracture of joint; 5. Gout arthritis of the knee; 6. Traumatic arthritis.
Contact & Investigator
Zhongwei Lv, MD
PRINCIPAL INVESTIGATOR
The 10th Hospital, Tongji University
Frequently Asked Questions
Who can join the NCT02993029 clinical trial?
This trial is open to participants of all sexes, aged 40 Years or older, studying Treatment Outcome. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT02993029 currently recruiting?
Yes, NCT02993029 is actively recruiting participants. Contact the research team at mc_7419@hotmail.com for enrollment information.
Where is the NCT02993029 trial being conducted?
This trial is being conducted at Shanghai, China.
Who is sponsoring the NCT02993029 clinical trial?
NCT02993029 is sponsored by Xinhua Hospital, Shanghai Jiao Tong University School of Medicine. The principal investigator is Zhongwei Lv, MD at The 10th Hospital, Tongji University. The trial plans to enroll 40 participants.